We Improve the Discoverability of Press Releases
NewsRamp™ is the PR and Newswire technology platform that transforms press releases into AI-optimized and multi-modal unique content formats designed to maximize discovery, engagement and global reach. NewsRamp™ primarily services newswires and news publishers.
Latest News
U.S. Bank Stocks Struggle in February 2026 Amid Market Uncertainty
about 4 hours ago
American Fusion's Kepler Aims for 1 GW Fusion Power by 2028
about 5 hours ago
Tonix's TONMYA Shows Rapid Fibromyalgia Pain Relief in New Data
about 5 hours ago
HR News
2026 Financial Wellness Awards Honor Top Workplace Solutions
about 6 hours ago
GVT Unveils Major FAMCare Upgrades for Human Services Agencies
1 day ago
HR.com Announces 2026 Leadership Development Award Winners
6 days ago
Global Hiring Accelerates Amid AI Reshaping and Engagement Strain in 2026
6 days ago
Fractional HR: Texas's Answer to Growth & Compliance Risks
13 days ago
Business News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
EdgeMode Accelerates AI Data Center Growth in Europe Post-BlackBerry Partnership
about 4 hours ago
Oragenics Advances Concussion Treatment with Phase IIa Trial Approval in Australia
about 4 hours ago
Crypto News
Crypto Payments Go Mainstream as Merchants Shift Focus to Efficiency & Security
about 4 hours ago
Bitcoin Bancorp to Present at NIBA Conference, Showcasing ATM Network Expansion
1 day ago
Crypto Market Slide in 2026: Grayscale Sees Long-Term Opportunity Amid Downturn
4 days ago
Utexo Raises $7.5M to Enable Bitcoin-Native USDT Settlement
4 days ago
Forward Industries Holds 6.97M SOL, Achieves 6.73% APY in Solana Treasury
5 days ago
Health News
OS Therapies' Osteosarcoma Treatment Advances Toward FDA Approval
in 7 months
OS Therapies Advances Breakthrough Osteosarcoma Treatment Toward Approval
in 7 months
Cingulate's ADHD Drug CTx-1301 Advances Toward 2026 FDA Decision
in 3 months
Oragenics Advances Concussion Treatment with Phase IIa Trial Approval in Australia
about 4 hours ago
HeartBeam and Mount Sinai Partner to Advance AI-Driven Cardiac Monitoring
about 5 hours ago
Technology News
EdgeMode Accelerates AI Data Center Growth in Europe Post-BlackBerry Partnership
about 4 hours ago
Europe Targets Social Media Giants with Investigations and Potential Youth Bans
about 4 hours ago
HeartBeam and Mount Sinai Partner to Advance AI-Driven Cardiac Monitoring
about 5 hours ago
American Fusion's Kepler Aims for 1 GW Fusion Power by 2028
about 5 hours ago
SS Innovations Reports 106% Revenue Growth, Expands Robotic Surgery Access Globally
about 6 hours ago
Events & Conferences
Frontieras Breaks Ground on $850M Green Energy Facility in West Virginia
about 5 hours ago
McEwen Sets 2025 Year-End Conference Call, Highlights Sustainable Copper Project
about 6 hours ago
Primaris Health Launches Executive-Focused Membership Model in Calgary
about 12 hours ago
Arkan Ventures Launches ESG-Focused Digital Health Roundtable Series
about 12 hours ago
HeartBeam Showcases Revolutionary 3D ECG Tech at Major 2026 Conferences
about 23 hours ago